1. Home
  2. OBK vs MPLT Comparison

OBK vs MPLT Comparison

Compare OBK & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Origin Bancorp Inc.

OBK

Origin Bancorp Inc.

SELL

Current Price

$51.90

Market Cap

1.6B

Sector

Finance

ML Signal

SELL

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$8.62

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBK
MPLT
Founded
1912
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
OBK
MPLT
Price
$51.90
$8.62
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
★ $59.20
$26.54
AVG Volume (30 Days)
156.9K
★ 418.3K
Earning Date
10-28-2026
08-13-2026
Dividend Yield
★ 1.94%
N/A
EPS Growth
N/A
★ 82.39
EPS
★ 1.97
N/A
Revenue
N/A
N/A
Revenue This Year
$11.68
N/A
Revenue Next Year
$7.47
N/A
P/E Ratio
$26.25
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.13
$8.70
52 Week High
$55.57
$40.43

Technical Indicators

Market Signals
Indicator
OBK
MPLT
Relative Strength Index (RSI) 40.47 25.82
Support Level $50.64 N/A
Resistance Level $53.05 $14.22
Average True Range (ATR) 0.93 0.59
MACD -0.14 0.02
Stochastic Oscillator 30.14 6.73

Price Performance

Historical Comparison
OBK
MPLT

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: